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Abstract 
The increased deposition of extracellular matrix by hepatic stellate cells following liver injury, in a process known as activation, is 
considered a key mechanism for increased collagen content of liver during the development of liver fibrosis. We report that N- 
(methylamino)isobutyric acid (MeAIB), a specific inhibitor of System A-mediated amino acid uptake, reduces the accumulation of 
collagen in CFSC-2G hepatic stellate cell cultures and in a rat model of liver injury and fibrosis. Rat CFSC-2G cells were cultured in 
0-5 mM MeAIB, and the accumulation and synthesis of collagen were measured by binding to Sirius red F3B and pulse-labeling with 
['HI-proline, respectively. The effect of MeAIB on collagen accumulation in vivo was evaluated utilizing a rat model of hepatic fibrosis. 
MeAIB inhibited collagen accumulation in CFSC-2G cultures in a concentration-dependent manner with 5 mM MeAIB reducing collagen 
44.6 * 1.2% compared with the control. In CFSC-2G cultures, MeAIB selectively inhibited the incorporation of proline into cellular 
macromolecules by 43 * 4%, while the synthesis of proteins containing leucine was not affected. In vivo, oral administration of 160 mg 
MeAIBIkg body weight per day to rats significantly reduced the hepatic collagen accumulation in response to 1 week of CCI4-induced 
liver injury. MeAIB reduces the accumulation of collagen in CFSC-2G hepatic stellate cell cultures and in a CC14-induced rat model of 
liver injury and fibrosis. 
Ke).words: Hepatic stellate cells; Liver fibrosis; Collagen; N-(Methy1amino)isobutyric acid 
1. Introduction 
HSCs are central to the deposition of fibrillar and non- 
fibrillar ECM proteins following hepatocellular injury. 
Quiescent HSCs have a lipid-storing phenotype and 
express low levels of matrix proteins, but following hepatic 
injury HSC transform to a myofibroblast-like phenotype, 
proliferate, express a-smooth muscle actin (a-SMA), and 
produce large quantities of ECM proteins, notably procol- 
lagen-I, in a process termed activation. Because the excess 
production of matrix proteins by activated HSC is thought 
to be the most direct contribution of HSC to hepatic 
fibrosis, any method of attenuating matrix production 
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RLU, relative luciferase units; a-SMA, a-smooth muscle actin; TCA, 
trichloroacetic acid. 
would have a profound influence on the development 
of cirrhotic liver disease [I-31. 
How activation of the HSC impacts the requirement of 
the cell for precursor molecules to fuel biosynthetic pro- 
cesses is largely unknown, but transformation from a 
quiescent lipid-storing cell to an activated myofibroblast, 
secreting large quantities of ECM protein, likely increases 
the demand of the cell for amino acids to fuel protein 
synthesis. In particular, the requirement for proline, which 
is highly enriched in collagen [4], is likely to be increased, 
and some investigations suggest that free proline is 
required for the efficient biosynthesis of collagen [5-71. 
Proline enters the cell and is concentrated predominately 
via a ~a+-dependent amino acid transport system known 
as "System A" [8,9], and this transport system can be 
inhibited competitively with MeAIB, a non-metabolizable 
amino acid analog [9]. The effect of interfering with the 
uptake and subsequent intracellular concentration of amino 
acids on ECM protein synthesis by HSC is unknown, and 
the effect of inhibiting System A-mediated proline trans- 
port on collagen synthesis by HSC has not been studied. 
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Due to the importance of increased hepatic collagen in 
the development of cirrhosis, methods of inhibiting col- 
lagen synthesis could prove beneficial in the treatment of 
fibrotic liver disease. Proline analogs such as L-3,4-dehy- 
droproline and L-azetidine-2-carboxylic acid have been 
reported to inhibit collagen synthesis [lo] and to partially 
ameliorate hepatic cirrhosis induced in rats by CC14 [I 11, 
respectively. However, both of these compounds compete 
with proline during the aminoacylation of tRNAPrO and are 
subsequently incorporated, in lieu of proline, into the 
growing peptide chains, a process that creates difficulties 
when separating the effects of amino acid uptake from 
those involving protein synthesis, modification, and secre- 
tion. MeAIB is a well-described inhibitor of proline uptake 
and is not metabolized or incorporated into cellular macro- 
molecules [12], making it an ideal candidate for studying 
the influence of amino acid uptake and intracellular con- 
centration on collagen biosynthesis. 
We investigated the influence of MeAIB treatment on 
collagen production by a cell line derived from rat HSC, 
which displays a myofibroblast-like phenotype closely 
resembling activated HSC, as well as in an in vivo experi- 
mental model of hepatic fibrosis. Our findings indicate that 
MeAIB inhibits collagen synthesis by preferentially redu- 
cing the synthesis of proteins containing proline, and that 
oral administration of MeAIB to rats reduces the amount of 
collagen accumulated in the liver following CC14-mediated 
hepatic injury. 
2. Materials and methods 
components, respectively, in the presence of picric acid 
[14,15]. Collagen content of paraffin-embedded rat liver 
sections was determined exactly as described by Jimenez et 
al. [14], and the collagen content of CFSC-2G HSC was 
determined by a modification of the original method. 
CFSC-2G HSCs were plated in 24-well dishes at a density 
that resulted in 70-80% confluence after a 24 hr incubation 
in standard MEM containing 10% FBS. Culture medium 
was then replaced with medium of the same type supple- 
mented with 0.1 mM ascorbate containing supplemental 
amino acids at the concentration indicated in the individual 
experiments. Some cells were fixed at this time with 10% 
phosphate-buffered formalin to serve as a baseline when 
determining the change in collagen accumulation over the 
following test interval. After 24 hr, the medium was aspi- 
rated, and the cells were fixed in 10% phosphate-buffered 
formalin. Cells were stained at room temperature as fol- 
lows: (i) 15 min in 0.5 mL of a solution containing 0.01% 
Fast green FCF, 0.5% picric acid in distilled water; (ii) 
15 min in 0.5 mL of a solution containing 0.04% Fast green 
FCF, 0.1% Sirius red, 0.5% picric acid in distilled water; 
and (iii) washing in tap water for 5-10 min until the elution 
fluid was completely clear. Cells were allowed to dry before 
elution of the bound dyes with 1 rnL of 50% methanol con- 
taining 50 mM NaOH. After a spectrum scan to establish 
the peak absorbances for each dye, the absorbance of the 
solution at 630 and 540 nm was determined by a spectro- 
photometer. Calculation of collagen and protein content 
was performed exactly as described [14], and the data are 
expressed as the change in collagen contentlmg total protein 
over the treatment interval to correct for collagen present in 
the cultures before the addition of the test compounds. 
2.1. Cell culture 
2.3. Measurement of collagen synthesis mte 
The cell line designated CFSC-2G [13] was derived 
from rat liver, has a phenotype similar to that of early 
passage primary HSC, and was provided by M. Rojkind 
(Albert Einstein College of Medicine). CFSC-2G cells 
were routinely cultured in standard MEM formulated by 
combining MEM (Sigma, Cat. no. M0268) with 1 x non- 
essential amino acids (Sigma, Cat. no. M-7145), 10 mM 
HEPES (pH 7.4), 10,000 unit penicillin with 10 mg strep- 
tomycinL, and 10% FBS (GibcoIBRL). Ascorbate was 
added at 0.1 rnM when indicated in the individual experi- 
ments. Incubation conditions were carried out at 37" with 
5% COz and 95% air. Cells were dissociated weekly in 
ca2+-free Hanks7 basal salt solution containing 0.25% 
trypsin and 0.5 mM EDTA, and then plated onto plastic 
at a 1 :4 dilution in standard MEM containing 10% FBS. 
The medium was changed biweekly. 
2.2. Collagen assays 
The collagen content of formalin-fixed samples was 
determined by the differential binding of Sirius red F3B 
and Fast green FCF to collagen and non-collagenous 
The rate of collagen synthesis in CFSC-2G HSC was 
determined by measuring the amount of L-[2,3,4,5-"1- 
proline (American Radiolabeled Chemicals, Inc.) incorpo- 
rated into collagenase digestible macromolecules [I 6,171. 
Cells were cultured in 24-well dishes and exposed to 
0.25 mL MEM (contains 0.1 mM non-labeled proline) 
supplemented with 0.1 mM ascorbate, 5 pCi [%]-proline, 
and amino acids as described in the individual experiments. 
After 2 hr of labeling, 0.25 mL of stop buffer (0.2% SDS 
containing 0.2 M NaOH) was added to terminate the 
labeling reaction and to solublize the cells. The lysate, 
which included secreted and intracellular collagen, was 
incubated at 80" for 10 min to inactivate protease activity 
and was then passed over a Sephadex G50 spin column 
equilibrated with TBS (100 mM NaCl, 10 mM Tris, pH 
7.5) to remove the unincorporated [3~]-proline and to 
change to a buffer suitable for digestion with purified 
collagenase. Collagen in the sample was digested for 
4 hr at 37" by combining 3.5 x lo4 to 5 x lo4 dpm labeled 
macromolecules with 5 unit of purified collagenase (form 
111, Advance Biofactures Corp.) and supplementing to 
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0.1 mM with CaC12. Collagenase-resistant material was 
precipitated with 10% trichloroacetic acid (TCA), and the 
soluble fraction was counted to quantify the [%]-proline 
liberated by collagenase digestion. Mock incubations were 
done in parallel to correct for background, and data were 
normalized to [3~]-proline incorporated into TCA-insolu- 
ble material prior to collagenase digestion. 
2.4. a2(I) procollagen reporter gene assay 
The expression of the a2(I) procollagen gene was 
monitored by transiently transfecting CFSC-2G HSC with 
a reporter plasmid, pGL1009, provided by Benoit de 
Crombrugghe (Anderson Hospital and Tumor Institute) 
as modified by Estaban Mezey and James Potter (Johns 
Hopkins University School of Medicine). Cells were plated 
on 24-well dishes to produce a density of 10-20% after a 
24 hr incubation in MEM containing 10% FBS. Transfec- 
tion of CFSC-2G cells with pGL1009 [IS] utilized the 
super~ectTM reagent (QIAgen). The medium was aspi- 
rated and replaced with 0.25 mL of serum-free MEM 
containing 1 pg plasmid DNA and 4 pL super~ectTM 
reagentlml. After incubation at 37" for 60 min, 1 mL 
MEM containing 10% FBS was added to each well, and 
the cells were incubated for an additional 24 hr, which 
resulted in a density of 70-80% confluence. Medium was 
aspirated and replaced with identical medium containing 0 
or 5 mM MeAIB, and luciferase activity was measured 
after a 12 hr incubation. Luciferase activity was assayed 
according to the instructions of the manufacturer using the 
Luciferase Assay System (Promega) and a TD-20120 
Luminometer (Turner Designs). 
2.5. Zymography of collagenase activity 
Collagen-degrading activity in culture medium condi- 
tioned by CFSC-2G HSC was assessed by zymography. 
Cells were plated in 24-well dishes with MEM and 10% 
FBS to yield 70-80% confluent cultures after 24 hr. The 
medium was aspirated and replaced with 0.3 mL of MEM 
supplemented with 0.1 mM ascorbate, 10% FBS, and 
amino acids as described in the individual experiments. 
Some experiments used serum-free conditions at this point 
when indicated. Cells were incubated at 37" with 5% C02  
and increased humidity to minimize evaporation of the 
medium. The medium was collected after 24 hr and frozen 
at -70". Zymography of secreted collagen degrading 
enzymes was conducted as described [19,20]. In brief, 
secreted proteins were resolved by non-reducing, native 
SDS-PAGE through an 8% resolving gel containing 0.1% 
gelatin (Sigma, porcine skin, type A, bloom 300), re- 
natured at room temperature by incubating the gel for 
30 min in several volumes of 2.5% Triton X-100, and 
developed by incubation at 37" for 16-1 8 hr in develop- 
ment solution (50 mM Tris, 200 mM NaCl, 5 mM CaC12, 
0.06% Brij-35, pH 8). Bands of enzyme activity were 
visualized by staining the gel with Coomassie blue 
(40% methanol, 10% acetic acid with 0.5% Coomassie 
brilliant blue R-250) and de-staining with 40% methanol 
containing 10% acetic acid. 
2.6. Determination of steady-state MeAIB, proline, 
and leucine levels 
The change in the steady-state level of intracellular 
amino acids was measured by a modification of a whole 
cell transport assay [21]. Cells were plated in 24-well 
dishes at a density to result in 70-80% confluence follow- 
ing incubation for 18-24 hr in MEM containing 10% FBS. 
The medium was aspirated and replaced with identical 
medium supplemented with a mixture of labeled and 
unlabeled test amino acid to produce a concentration of 
0.2 mM and a specific activity of 1 pCilmL (-5 mCilmmol 
final), and the unlabeled competing amino acid was added 
at 0, 0. I, 0.5, 1, or 5 mM. The cells were incubated at 37" 
with 5% C02  for 90 min to ensure that steady-state con- 
ditions were achieved. Extracellular label was removed 
with three rapid washes in 1 mL of ice-cold Krebs-Ringer 
bicarbonate buffer (Sigma). Cells were disrupted with 
0.2 mL of 0.1% SDSlO.1 M NaOH, and the released 
labeled amino acid was quantified by scintillation count- 
ing. Protein content was determined by the Lowry method 
for normalization, and the incorporation of label into 
macromolecules was corrected by measuring the TCA- 
insoluble radioactivity. [N-~eth~l-%]aminoisobutyric 
acid (60-80 mCiImmol), L- [2,3,4,5-%]-proline (90-1 20 
Cilmmol), and L-[4 ,5-3~(~]- leuc ine  were purchased from 
American Radiolabeled Chemicals, Inc., and unlabeled 
amino acids of the highest available purity were purchased 
from the Sigma. 
2.7. Measurement of proline and leucine incorporation 
into protein 
The rate at which proteins containing leucine or proline 
were synthesized was measured by pulse-label experi- 
ments. CFSC-2G HSCs were exposed to standard MEM 
containing 10% FBS, 20 pCilmL of ['HI-proline or ['HI- 
leucine, and either 0 or 5 mM MeAIB for 60 min. The 
medium was aspirated, and the cells were solublized in 
0.1% SDS containing 0.1 M NaOH. Cell lysates were 
combined with 100 pg of carrier protein (BSA) and pre- 
cipitated with 10% TCA. Precipitated proteins were col- 
lected by filtration under vacuum over glass fiber disks 
followed by two washes in ice-cold 5% TCA and two 
washes with acetone. Radioactivity in macromolecules 
was measured by scintillation counting. 
2.8. In vivo model of liver fibrosis 
Our experimental model of CC14-induced liver fibrosis 
was adapted from the methods described by Iredale 
700 TL.  Freeman et al. /Biochemical Pharmacolog)~ 63 (2002) 697-706 
et al. [22]. Adult male Sprague-Dawley rats (200-250 g) 
were obtained from Harlan Sprague Dawley. Protocols 
were approved by the Omaha VA Medical Center Institu- 
tional Animal Care and Use Committee and complied 
with the guidelines set by the National Institutes of 
Health. Rats were maintained under a controlled tem- 
perature with a 12 hr light-dark cycle for at least 5 days 
before use in experiments. Standard rodent chow and 
de-ionized water were provided ad libitum. Induction 
of liver injury and progressive fibrosis were produced 
by biweekly intraperitoneal injections of 0.2 mL CC14, 
in a 1 : 1 (vlv) ratio with peanut oil. MeAIB was adminis- 
tered by inclusion of I g MeAIBIL of drinking water 
for 3 days prior to the first CC14 injection. Animals were 
anesthetized with 100 mg ketamine containing 0.1 mg 
acepromazine, and tissues were harvested 10 and 17 days 
following the first CC14 injection. Injections of CC14 
were scheduled so that livers were collected 3 days 
following the last CC14 treatment. Control livers were 
harvested from rats 3 days following MeAIB treatment 
and were not exposed to CC14. Blood was collected 
by heart puncture and stored at -70" following removal 
of the non-serum components by centrifugation. One 
lobe of each liver was fixed in buffered formalin for 
production of paraffin-embedded sections, while the 
remainder was stored frozen at -70" until needed for 
immunoblotting. 
2.9. Western blotting 
a-SMA was detected in liver homogenates by standard 
Western blotting [23], utilizing a monoclonal anti-a-SMA 
antibody probe (clone 1A4, Sigma). Liver samples were 
homogenized by grinding in a buffer containing 1 % SDS, 
0.1 mM EDTA, and 10 mM Tris (pH 8) followed by 
incubation at 80" for 20 min. Insoluble material was 
removed by centrifugation (10 min at 10,000 g at room 
temperature), and protein content was determined by 
the Lowry assay. Liver proteins (100 pg) were separated 
by denaturing SDS-PAGE and transferred to nitrocellu- 
lose by electro-blotting. Nitrocellulose was blocked with 
2% BSA in TBST (150 mM NaC1, 10 mM Tris, 0.02% 
Tween 20, pH 7.5) for 2 hr followed by incubation with 
primary anti-a-SMA at 4" for 16-18 hr. Visualization 
of primary antibody was with alkaline phosphatase- 
conjugated anti-mouse IgG and BCIPINTB using standard 
methods. 
2.10. Statistical analysis 
Each data point represents the mean f SD of a minimum 
of three determinations or the number of replicates (N 
value) indicated in the individual experiments. Signifi- 
cance was evaluated utilizing Student's t-test with 
P < 0.01 and P < 0.05 set as statistically significant in 
vitro and in vivo, respectively. 
3. Results 
3.1. Collagen accumulation in cultured CFSC-2G cells 
Differential binding of Sirius red F3B and Fast green 
FCF to collagen and non-collagenous components was 
utilized to quantify the amount of collagen present in 
CFSC-2G cultures [14,15]. These results were confirmed 
by continuous labeling with ['HI-proline over 24 hr fol- 
lowed by determination of the collagen content [16,24], 
which produced representative results (data not shown). As 
illustrated in Fig. 1, the addition of MeAIB reduced the 
amount of collagen present in cultures of CFSC-2G HSC. 
The effect was concentration-dependent with concentra- 
tions of MeAIB 1 mM or below having little or no effect on 
the accumulation of collagen by the cells over a 24 hr 
period. MeAIB concentrations at or above 2.5 mM 
decreased the amount of collagen by 40.5 f 1.8, 
44.6 f 1.2, and 42.1 f 2.3% compared with control at 
2.5, 5, and 10 mM MeAIB, respectively. The effect of 
MeAIB on the accumulation of collagen by CFSC-2G HSC 
was maximal at 5 mM with higher concentrations of 
MeAIB unable to inhibit collagen production further. 
MeAIB did not reduce significantly the total amount of 
protein measured by Fast green FCF binding in samples 
treated with 5 mM or less MeAIB, but 10 mM MeAIB 
reduced the amount of total protein by 6.8 f 1.7%. Since 
5 mM MeAIB was the lowest concentration that resulted in 
a maximal reduction in collagen accumulation over a 24 hr 
period without interfering with non-collagenous protein 
synthesis, this concentration was used in all subsequent 
experiments. 
3.2. Inhibition of collagen synthesis by MeAIB 
Because 5 mM MeAIB reduced the accumulation of 
collagen in CFSC-2G HSC, the effect of MeAIB on the 
[MeAIB, mMj 
Fig. 1. Collagen accumulation by CFSC-2G cultures. CFSC-2G cells were 
cultured in medium supplemented with the indicated concentration of 
MeAIB as described in Section 2. Asterisks indicate significance by 
Student's t-test at P < 0.01 vs. 0 mM MeAIB. Data represent the 
means f SD of three independent experiments (N = 9). 
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Fig. 2. Collagen synthesis rate by cultures of CFSC-2G cells. Collagen 
synthesis was measured with and without 5 mM MeAIB by incorporation 
of ['HI-proline into collagenase-digestible macromolecules as described in 
Section 2. Data are normalized to total incorporation of [iH]-proline into 
TCA-insoluble material before digestion. The asterisk indicates signifi- 
cance by Student's t-test at P < 0.01. Data are the means f SD of three 
determinations and are representative of three independent experiments. 
rate of collagen synthesis was investigated as a possible 
cause for this reduction. The sensitivity of proteins pulse- 
labeled with ['HI-proline to collagenase was utilized as a 
measure of the collagen synthesis rate of CFSC-2G cells. 
As shown in Fig. 2,3.2 f 0.5% of the proline incorporated 
into protein over a 2 hr period was directed to collagen. 
MeAIB (5  mM) reduced the synthesis of collagen to 
1.1 f 0.4% of the cellular proline incorporation. These 
results indicate that inclusion of 5 rnM MeAIB decreased 
the incorporation of [%~-~rol ine into collagen by 2.9-fold, 
demonstrating a profound inhibitory effect of MeAIB on 
collagen synthesis by CFSC-2G cells. 
3.3. a2(I) procollagen gene expression 
The effect of the amino acid analog MeAIB on collagen 
synthesis could potentially result from perturbation of 
transcriptional or post-transcriptional processes. The 
expression of the x2(I) procollagen gene was investigated 
to examine changes in collagen gene expression following 
MeAIB treatment. A reporter gene, luciferase, fused to the 
a2(I) procollagen promoter was used to quantify any 
changes in gene expression. The addition of 5 mM MeAIB 
did not have an effect on gene expression under the control 
of the a2(I) procollagen promoter. Transfected CFSC-2G 
cells expressed 4.4 f 0.78 RLUImg protein after 12 hr 
in control medium, and paired cultures expressed 4.8 f 
0.92 RLUImg protein after 12 hr in medium containing 
5 mM MeAIB. These data show that decreased collagen 
synthesis in CFSC-2G cells following MeAIB treatment 
could not be attributed to an attenuation in the transcrip- 
tional expression by the x2(I) procollagen promoter. 
3.4. Secretion o f  collagen-degrading enzymes 
The net accumulation of collagen is dependent upon the 
rate of collagen synthesis and the rate of collagen degrada- 
tion. Since the accumulation and synthesis of collagen 
were inhibited by MeAIB, experiments were conducted 
to examine any change in the collagen-degrading activity 
in culture medium harvested from CFSC-2G cells. 
Zymography was utilized to: (i) measure the amount of 
collagen-degrading activity in culture medium conditioned 
by CFSC-2G cells; and (ii) provide additional information 
on the different species of collagen-degrading enzymes 
produced. An unexpected finding was the large amount of 
collagenase activity present in unconditioned medium 
containing 10% FBS (lane 7, Fig. 3A). In medium contain- 
ing 10% FBS, the preponderance of collagen-degrading 
activity was derived from the bovine sera and not the 
CFSC-2G HSC. However, the collagen-degrading activity 
attributable to the CFSC-2G cells did not change with the 
inclusion of 5 mM MeAIB or 5 mM alanine plus 5 mM 
MeAIB as seen in Fig. 3A by comparing the activity found 
in conditioned medium (lanes 1-6) with the activity found 
in unconditioned medium (lane 7). To better visualize the 
collagenase activity in medium conditioned by CFSC-2G 
HSC, the experiment was duplicated under serum-free 
Fig. 3. Collagen-degrading activity of CFSC-2G cells. Collagenase activity in culture medium conditioned by CFSC-2G cells was assayed by zymography as 
described in Section 2. Medium containing 10% FBS (panel A) or serum-free medium (panel B) were conditioned by incubation with CFSC-2G cell cultures 
for 24 hr before determination of secreted collagenase activity by zymography. Treatment conditions were control medium (lanes 1 and 2), medium 
containing 5 mM MeAIB (lanes 3 and 4), or medium containing both 5 mM MeAIB and 5 mM alanine (lanes 5 and 6).  Unconditioned medium containing 
10% FBS was included in lane 7 as a reference. Cells were plated in a paired manner, and treatments were performed in duplicate. Results are representative 
of two experiments. 
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conditions as described in Section 2. MeAIB did not 
change the collagen-degrading activity in serum-free 
CFSC-2G cell-conditioned medium, as seen in Fig. 3B. 
Because the collagen-degrading activity of CFSC-2G HSC 
conditioned medium did not change in response to treat- 
ment of the cells with 5 mM MeAIB, the reduction in 
collagen accumulation resulting from MeAIB treatment 
could not be attributed to altered production of collagen- 
degrading enzymes. 
3.5. Effect of exogenous amino acids on collagen 
Since MeAIB inhibits the uptake of small neutral amino 
acids into the cell by cis and trans effects on the System A 
transporter [9], we reasoned that providing excess amounts 
of exogenous amino acids may reverse the effect of MeAIB 
on collagen synthesis. However, alanine, glycine, and 
proline were unable to reverse the effect of MeAIB on 
the accumulation of collagen in cultures of CFSC-2G HSC. 
As seen in Fig. 4, the addition of 5 mM alanine, proline, or 
glycine did not reverse the 40-50% reduction in collagen 
accumulation in CFSC-2G HSC cultures. Moreover, the 
simultaneous addition of 5 rnM alanine, proline, and gly- 
cine had no significant effect on collagen accumulation in 
the absence of MeAIB. Additional experiments found that 
the simultaneous addition of 5-10 mM alanine, proline, 
and glycine was no more effective at reversing the effect of 
MeAIB than when single amino acids were used. These 
data indicate that the effect of MeAIB on collagen accu- 
mulation is not reversible by the addition of exogenous 
amino acids, and also that exogenous alanine, proline, and 
glycine do not inhibit collagen accumulation in CFSC-2G 
HSC cultures in the absence of MeAIB. 
M MA MP MG C APG 
Fig. 4. Effect of exogenous amino acids on collagen accumulation. CFCS- 
2G HSCs were incubated for 18-24 hr in medium containing 5 mM 
MeAIB (M), 5 mM MeAIB plus 5 mM alanine (MA), 5 mM MeAIB plus 
5 mM proline (MP), 5 mM MeAIB plus 5 mM glycine (MG), no 
supplemental amino acids (C), or 5 mM alanine, 5 mM proline, plus 
5 mM glycine (APG). Collagen content was determined by the differential 
binding of Sirius red F3B and Fast green FCF to collagen and non- 
collagenous components, respectively, in the presence of picric acid as 
described in Section 2. Data are the means f SD of four replicates and are 
representative of three independent experiments. Asterisks indicate 
significance at P < 0.01 vs. no supplemental amino acids (C). 
3.6. Intracellular MeAIB, proline, and leucine levels 
Because exogenous amino acids were not able to 
reverse, or even partially reverse, the inhibitory effect of 
MeAIB on collagen accumulation, studies were conducted 
to examine the influence of MeAIB on the intracellular 
level of naturally occurring amino acids at steady-state 
conditions. The steady-state accumulations of proline and 
leucine were chosen for study because MeAIB is known to 
inhibit the uptake of proline competitively, while having 
little or no inhibitory effect on leucine uptake [9]. As 
expected, MeAIB reduced the accumulation of intracel- 
lular proline in a concentration-dependent manner. MeAIB 
had virtually no effect on the accumulation of intracellular 
leucine (Fig. 5A). In the absence of MeAIB, proline 
accumulated to a high level of 5.28 f 0.37 nmollmg pro- 
tein due to the active transport of proline in a process 
dependent upon the Na+ gradient of the plasma membrane. 
Addition of 0.1-5 mM MeAIB reduced the intracellular 
proline level by a maximum of 54 f 7%. The steady-state 
level of leucine was lower than that of proline due to the 
passive uptake of leucine by the Na+-independent leucine 
transport system, and the addition of MeAIB did not alter 
a,- .c 0 -
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Fig. 5. Intracellular proline and leucine content of CFSC-2G cells. 
Intracellular proline, leucine, and MeAIB were measured utilizing 
radioactive tracers as described in Section 2. Panel A illustrates the effect 
of 0-5 mM MeAIB on intracellular proline ( 0 )  or leucine ( 0 )  levels. 
Panel B shows the effect of 0-5 mM proline ( 0 )  or 0-5 mM leucine ( 0 )  
on intracellular MeAIB accumulation. Data are the means f SD of two 
independent experiments composed of four replicates (N = 8). 
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the intracellular level of leucine significantly. Experiments 
were also done to examine the ability of proline or leucine 
to influence the accumulation of intracellular MeAIB. 
Paradoxically, proline was not able to decrease the intra- 
cellular level of MeAIB (Fig. 5B). MeAIB accumulated to 
4.94 f 0.18 nmollmg protein, a level nearly identical to 
that reached by proline. Leucine, as expected, did not have 
an effect on the intracellular level of MeAIB. These 
findings demonstrate that MeAIB inhibits the intracellular 
accumulation of proline, but proline is unable to influence 
the accumulation of intracellular MeAIB. 
3.7. Proline and leucine incorpomtion into protein 
Because MeAIB reduced the intracellular level of pro- 
line while leaving the level of leucine unchanged, the 
hypothesis that synthesis of proteins containing proline 
should be affected to a greater degree by MeAIB than 
proteins containing little or no proline was investigated. 
This idea was tested by pulse-labeling CFSC-2G HSC with 
[3~]-proline or [3~]-leucine in the presence or absence of 
5 mM MeAIB. As summarized in Fig. 6, the incorporation 
of [%]-proline into protein was inhibited 43 f 4% by 
5 mM MeAIB, but MeAIB had no effect on the incorpora- 
tion of [3~]-leucine into TCA-insoluble macromolecules. 
This result demonstrates that proteins containing proline 
are more sensitive to the effect of MeAIB than proteins 
containing little or no proline. 
3.8. Collagen accumulation in vivo 
Studies were also conducted to determine if the MeAIB- 
mediated inhibition of collagen synthesis and accumula- 
tion in CFSC-2G HSC produced similar results in an 
animal model of hepatic injury and fibrosis. While mea- 
suring collagen synthesis rates by HSC in vivo presents a 
0 1 2 
Time (weeks of CC1,treatment) 
Fig. 7. Collagen content in the liver of CC14-treated rats. Animals were 
given drinking water (black bars) or 1 g MeAIBIL of drinking water (gray 
bars) for 3 days before treatment with CCI,, and the liver collagen content 
was determined 0 (before liver damage), 1, and 2 weeks following 
experimental liver damage as described in Section 2. Data are the 
means f SD of four determinations. P values are indicated by asterisks: 
P < 0.04 (*) and P < 0.06 (**). 
significant technical challenge, the measurement of col- 
lagen accumulation in liver sections following injury is 
relatively straightforward; therefore, the amount of col- 
lagenlmg of liver protein was used as a measure of effec- 
tiveness in the in vivo model. Addition of 1 g MeAIBL of 
drinking water reduced the hepatic collagen content of 
liver in a CC14-induced model of hepatic fibrosis (Fig. 7). 
Both control and MeAIB-treated animals had increased 
hepatic collagen following 1 and 2 weeks of CC14 adrnin- 
istration compared with liver before treatment. Control 
animals contained 13 1 f 18 and 155 f 12 yg collagenlmg 
liver protein, while MeAIB treatment reduced the hepatic 
collagen to 108 f 18 and 128 f 15 yg collagenlmg liver 
protein following 1 or 2 weeks of liver damage, respec- 
tively. While the reduction in hepatic collagen was rela- 
tively modest, MeAIB did produce a statistically 
significant reduction 1 week into the in vivo model of 
liver fibrosis. Despite an apparent reduction in collagen, 
the amount of hepatic collagen present 2 weeks into the 
treatment just missed statistical significance between the 
two groups with P < 0.06. 
3.9. a-SMA levels following liver injury 
Fig. 6. Incorporation of proline or leucine into macromolecules. The 
incorporation of proline or leucine into CFSC-2G cellular proteins was 
measured by pulse-label experiments as described in Section 2. Control 
medium and medium containing 5 mM MeAIB are indicated by black or 
gray bars, respectively. Data are the means f SD of four replicates and are 
representative of three independent experiments. The asterisk indicates 
significance at P < 0.01. 
An indication of HSC activation is the de novo synthesis 
of a-SMA [2]. Western blotting revealed that a-SMA was 
increased following CC1,-induced liver injury, and that oral 
administration of MeAIB reduced the a-SMA present in 
liver, indicating that MeAIB potentially inhibited the 
activation of HSC (Fig. 8). 
3.10. Blood liver enzymes ,following liver injury 
Blood GOT enzyme activity was monitored as an 
indicator of hepatocyte injury in response to the CC14 
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SMA- 
Fig. 8. &MA in liver following CC14-induced hepatic injury. Animals 
were treated as described in the legend of Fig. 7, and livers were harvested 
after I week of CC14 treatment. &MA was detected in homogenized liver 
by Western blotting. Lane 1 contains liver proteins from animals before 
CC14 treatment as a reference. Lanes 2 and 3 contain liver samples from 
animals receiving drinking water or I g MeAIB/L of drinking water, 
respectively, beginning 3 days before CCld treatment. Data are 
representative of three experiments. 
0 1 2 
Time (weeks of CC14 treatment) 
Fig. 9. GOT enzyme activity in blood of CCI,-treated rats. Animals were 
provided drinking water (black bars) or I g MeAIBIL of drinking water 
(gray bars) exactly as described in the legend of Fig. 7, and blood plasma 
levels of the liver enzymes were determined. Data are the means f SD of 
four determinations. The asterisk indicates significance at P < 0.01. 
injections. We found that oral treatment with MeAIB 
reduced the GOT enzyme level present in the serum 
fraction of blood by 38 f 11% after 1 week of CCL- 
induced liver injury (Fig. 9). The hepato-protective effect 
of MeAIB was not observed after 2 weeks of CC1,-induced 
liver injury. 
4. Discussion 
We report here that MeAIB treatment effectively 
reduces the accumulation of collagen in an in vitro model 
of activated HSC and in an in vivo rat model of liver injury 
and fibrosis. MeAIB was found to decrease collagen 
accumulation in cultures of CFSC-2G HSC by inhibiting 
the synthesis of cellular proteins containing proline. Atte- 
nuated gene expression of x2(I) procollagen or increased 
secretion of collagen-degrading enzymes could not 
account for the reduction in collagen accumulation in 
response to MeAIB treatment. In vivo, oral administration 
of - 160 mg MeAIBIkg per day to rats significantly 
reduced the hepatic collagen accumulation resulting from 
1 week of CC14-mediated liver injury. MeAIB also dis- 
played a hepato-protective property as demonstrated by 
reduced GOT enzyme activity found in peripheral blood 
following 1 week of liver injury. The decrease in a-SMA 
expression in liver following CC1,-mediated injury result- 
ing from MeAIB treatment indicated that MeAIB also 
potentially interfered with HSC activation either directly 
or indirectly by reducing hepatic damage. These data 
provide evidence that mechanisms of reducing the avail- 
ability of proline to HSC can provide a novel method for 
inhibiting collagen synthesis and accumulation in response 
to hepatic injury. 
The inhibition of collagen accumulation by MeAIB 
appears to result from selectively impairing the synthesis 
of proteins containing proline residues. The results of this 
study showed that the incorporation of proline into CFSC- 
2G cell proteins was inhibited nearly 50% by 5 mM 
MeAIB while the incorporation of leucine was unaffected. 
Neither a2(I) procollagen promoter-driven gene expression 
nor collagen-degrading enzyme activity was affected by 
including 5 mM MeAIB in the culture medium. Because 
MeAIB did not appear to affect general protein synthesis, 
as seen by the lack of an effect by MeAIB on the incor- 
poration of leucine into proteins, and because many pro- 
teins other than collagen contain proline residues, it is 
reasonable to speculate that proteins containing large 
numbers of proline residues should be more sensitive to 
the inhibitory effect of MeAIB than proteins containing 
very few prolines. Our finding, that MeAIB can reduce the 
accumulation and synthesis of collagen (a protein enriched 
with proline residues) while having no measurable effect 
on non-collagenous proteins, supports this idea. 
Because MeAIB and proline share the same transport 
system to gain entry into the cell [8,9], a plausible expla- 
nation for the reduction in proline incorporation into 
protein is the limitation of proline availability for protein 
synthesis due to the effect of MeAIB on the uptake and 
subsequent cytoplasmic accumulation of proline. MeAIB 
reduced the intracellular concentration of proline, in a 
concentration-dependent manner, by a maximum of 55% 
in CFSC-2G cells, while the intracellular accumulation of 
leucine was not affected by MeAIB. These data correlate 
well with the incorporation of proline and leucine into 
proteins in the presence of 5 mM MeAIB. 
Care must be taken not to assign all of the effect exerted 
by MeAIB solely to inhibiting the uptake of proline, 
because MeAIB has been described previously to have 
the unusual property of displacing intracellular amino 
acids while not being influenced by the presence of other 
amino acids [9]. In this regard, MeAIB effectively 
decreased the intracellular concentration of proline, but 
proline was not able to reduce the intracellular concentra- 
tion of MeAIB. The inability of exogenous alanine, pro- 
line, or glycine to even partially reverse the effect of 
MeAIB on collagen accumulation in CFSC-2G cultures 
provides additional evidence indicating that simple 
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competitive inhibition of amino acid uptake by MeAIB 
may not fully explain the inhibitory properties of MeAIB 
on the synthesis of collagen. 
While the mechanism of this ability of MeAIB to reduce 
intracellular amino acid accumulation without being dis- 
placed itself is not fully understood, this property likely 
results in a further reduction in the cellular availability of 
specific amino acids and influences the physiology of the 
cell in ways that are difficult to predict. We hypothesize 
that MeAIB treatment results in an insufficient supply of 
the amino acids that predominantly gain entry into the cell 
via the System A amino acid uptake pathway, of which pro- 
line is the prime example. This would lead to a decreased 
number of aminoacylated tRNAPro molecules eventually 
impacting the synthesis of proteins containing proline. It is 
unlikely that the mechanism involves an alteration in the 
behavior of ribosomes, or a generalized down-regulation 
in protein synthetic rates, because the incorporation of 
leucine into protein was unaffected by MeAIB, indicating a 
process selective for proteins containing proline. Despite 
incomplete information on the precise mechanism for 
selectively inhibiting the synthesis of proline-containing 
proteins, MeAIB did inhibit effectively the production of 
proline-enriched proteins, such as collagen, in CFSC-2G 
cells as well as in liver following experimental injury. 
In the rat model of hepatic injury and fibrosis, oral 
administration of MeAIB also resulted in the decreased 
accumulation of liver collagen. Significant reduction in 
hepatic collagen was observed after 1 week of CC14- 
induced liver injury, but MeAIB treatment did not produce 
a statistically significant change in hepatic collagen con- 
tent after 2 weeks of treatment. While the 18% decrease in 
total hepatic collagen due to MeAIB appears modest after I 
week of treatment, the inhibition of the collagen increase 
(i.e. when compared with liver collagen content before 
injury) was more telling with collagen increasing 21 1 f 32 
and 168 f 21% in control and MeAIB-treated animals, 
respectively. This indicates that MeAIB inhibited the 
increase in hepatic collagen, above the uninjured liver 
content, by as much as 38-43% over the first week of 
treatment. Why MeAIB treatment did not produce statis- 
tically significant reductions in hepatic collagen 2 weeks 
into treatment is unclear, but the data did maintain a 
downward trend and only missed significance slightly 
(P < 0.06). How modification of the dosage of MeAIB 
would influence the accumulation of collagen was not 
studied, but it is likely that increasing the daily dose of 
MeAIB would reduce the accumulation of hepatic collagen 
further, possibly resulting in statistically significant reduc- 
tions beyond the first week of treatment. 
Previous studies report that much higher doses of 
MeAIB produce no obvious toxic side-effects in rats 
[12,25]. In this study, including 1 g MeAIBIL of drinking 
water produced a daily dose of 159 f 33 mg MeAIBkg 
body weight as calculated from the daily water utilization. 
Water intake was not significantly different between the 
groups (data not shown). This dose is quite modest com- 
pared with reports in the literature giving MeAIB to rats at 
doses of 1.17 g k g  per day for 8 consecutive days [12]. 
Also, rats do not have increased mortality rates following 
resection of 68-70% of their liver with the concurrent 
intraperitoneal injection of up to I0 g MeAIBIkg [25], 
which is 60 times greater than the oral dose given in this 
study. Because higher doses of MeAIB can be well toler- 
ated by the rat, even under conditions of reduced liver 
capacity, it is quite likely that increasing the dose of 
MeAIB could further reduce the hepatic collagen content 
without exhibiting an overt toxic effect. However, this has 
yet to be tested experimentally and was beyond the scope 
of this study. 
In addition to reducing the hepatic collagen content, the 
decreased expression of a-SMA by MeAIB treatment in 
liver 1 week following CC14-induced liver injury indicates 
that this agent potentially interfered with the activation of 
HSC. Furthermore, previous studies by our laboratory 
indicate that MeAIB can inhibit the proliferation of hepa- 
tocytes following partial hepatectomy [25]. Because HSC 
activation is closely coupled to HSC proliferation [2], 
MeAIB treatment could have the additional property of 
inhibiting HSC activation, provided that the antiprolifera- 
tive properties of MeAIB extend to HSC. In fact, unpub- 
lished experiments by our laboratory indicate that MeAIB 
treatment partially inhibits the rapid induction of a pro- 
liferative burst by serum-starved CFSC-2G cultures fol- 
lowing stimulation with 10% FBS. 
It is interesting to also note that the MeAIB-mediated 
reduction in hepatic a-SMA following CC14-induced liver 
injury could indicate reduced activation of quiescent HSC 
due to the apparent hepato-protective property of MeAIB. 
Because MeAIB treatment reduced the blood level of 
enzymes indicative of hepatic injury, the degree of hepatic 
injury was likely smaller in the MeAIB-treated animals, 
which would suggest attenuated liver damage and corre- 
sponding hepatic inflammation, the key inducer of HSC 
activation [26,27]. How MeAIB produces a hepato-pro- 
tective effect is not known, but similar hepato-protective 
observations have been made for molecules with similar 
structures, such as betaine [28], alanine [29], and glycine 
[30]. Overall, these data indicate that MeAIB may reduce 
hepatic collagen accumulation by preventing HSC activa- 
tion, either directly or indirectly by preventing liver injury, 
in addition to inhibiting collagen production by activated 
HSC. 
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